To thoroughly implement the spirit of the high-quality development meetings at the provincial, municipal, and district levels, and focus on the goal of strengthening the biopharmaceutical industry chain within the district, Guangzhou Development District Industry Fund Investment Group Co., Ltd.

On May 10, 2023, the thematic salon "Clinical Studies, Efficiency First"—Biomatrix Medicine Talk, co-hosted by UnionClin and Biomatrix, concluded successfully in Nanjing.

From April 7 to 9, 2023, the China Innovative Drug (Device) Medical Conference and CMAC Annual Meeting were successfully held at the Suzhou International Expo Center.

On April 1, the First National Medical Center for Infectious Diseases Infection Cooperation Forum & the First Oriental International Infection Week (Oriental ID Week), jointly organized by the National Medical Center for Infectious Diseases (NMCID), Fudan University Huashan Hospital, Shanghai Fudan University Education Development Foundation, and Shanghai Huashen Institute of Microbiology and Infection, were held in Shanghai.

Recently, the 2022 Shanghai Jing'an Park "Zhangjiang Star" Enterprise Cultivation Work Exchange Meeting was successfully held. The meeting introduced the "Zhangjiang Star" enterprise cultivation work and awarded plaques to the 2022 "Zhangjiang Star" enterprises. Shanghai UnionClin Co., Ltd.

Recently, Shanghai UnionClin Co., Ltd. signed a strategic cooperation agreement with Chongqing University Cancer Hospital regarding the development and application services of an innovative oncology drug clinical study system for the Phase I ward.